Sitagliptin N-formyl impurity
| Product Name | Sitagliptin N-formyl impurity |
|---|---|
| Alternate Names | Sitagliptin Impurities, Impurities of Sitagliptin |
| CAT No. | CS-O-34416 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 435.32 g/mol |
| Mol. For. | C₁₇H₁₅F₆N₅O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Sitagliptin |
| Purity | 95% |
| Smileys | O=CNC(CC(N1CC2=NN=C(C(F)(F)F)N2CC1)=O)CC3=CC(F)=C(F)C=C3F |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Sitagliptin is a medication used to treat type 2 diabetes. It works by increasing the levels of certain hormones in the body that stimulate the pancreas to produce insulin and regulate blood sugar levels. Sitagliptin N-formyl impurity is a byproduct that may be present in sitagliptin formulations, and it is important to understand its chemical properties and potential effects on patients.
The N-formyl impurity is a small organic molecule with a molecular weight of around 245 grams per mole. It is formed during the manufacturing process of sitagliptin and may be present in trace amounts in the final product. While the impurity has not been extensively studied, it is believed to be relatively stable and non-reactive, and is not expected to significantly affect the efficacy or safety of sitagliptin.
However, as with any medication, it is important to closely monitor patients for adverse effects. In rare cases, the impurity could potentially cause allergic reactions or other adverse effects. Patients who experience any unusual symptoms while taking sitagliptin should consult their healthcare provider immediately.
Overall, sitagliptin N-formyl impurity is a minor byproduct that is generally considered to be safe and well-tolerated. Its presence in sitagliptin formulations is carefully controlled to ensure the safety and efficacy of the medication for patients with type 2 diabetes.
Get an Instant Quote
Related Compounds
Sitagliptin Impurity 28 | Sitagliptin impurity I | Sitagliptin impurity H Hydrochloride | Sitagliptin Triazecine Analog | Sitagliptin impurity T | Sitagliptin impurity D | Sitagliptin Dioxo SODIUM Impurity | Sitagliptin Amino Acid Impurity | Sitagliptin hydroxylimine impurity | Sitagliptin impurity R | SITAGLIPTIN FORMIC ACID ADDUCT | Rac-Sitagliptin Triazecine Analog | Sitagliptin impurity F | Sitagliptin EP Impurity C | Sitagliptin FP Impurity D | Sitagliptin Acid Pivaloyl impurity | Sitagliptin impurity G | Sitagliptin EP Impurity C | Sitagliptin N-Acetyl Impurity | Sitagliptin impurity-4 | Sitagliptin Fumarate Adduct | Sitagliptin Impurity 93 | Sitagliptin EP Impurity C Phosphate | Sitagliptin Impurity 39 | Sitagliptin Impurity H | Sitagliptin Impurity 84 | Oxo Sitagliptin | Sitagliptin Impurity 40 | Sitagliptin Amide impurity | Sitagliptin isopropyl ester impurity | Sitagliptin impurity K | Sitagliptin impurity N | Sitagliptin Styrylacetyl Analogue | Sitagliptin phosphate (Monohydrate) | Sitagliptin nitroso impurity | Sitagliptin Impurity 62 | Sitagliptin FP Impurity D (Z)-Isomer | Sitagliptin dioxo impurity | Sitagliptin impurity J | Sitagliptin EP Impurity E | N-Nitroso Sitagliptin Fumarate Adduct | Sitagliptin Phosphate Hydrate | Sitagliptin Pyrazine Impurity | Sitagliptin EP Impurity A | Sitagliptin tartrate hemihydrate | Sitagliptin impurity L | Sitagliptin Enamine Impurity | Nitroso Sitagliptin | Sitagliptin Triazecine Analog-D4 | Sitagliptin Impurity 61 |